Newer evidences and recommendations regarding the cardiovascular risk reduction by lipid treatments, antidiabetic medications, and other endocrine-metabolic methods
█ Review
DOI: 10.26430/CHUNGARICA.2022.52.4.324
Authors:
|
click here to read the summary |
click here to read the pdf |
|
Watch the video summary | watch CH Live interview |